Precision oncology via artificial intelligence on cancer biopsies
A new generation of artificial intelligence (AI) tools designed to allow rapid, low-cost detection of clinically actionable genomic alterations directly from tumor biopsy slides has been developed by a team led by engineers and medical researchers at University of California San Diego. A paper describing the new AI protocol for examining routine biopsies, called DeepHRD, … Read more
